Femoral Nerve Block vs Peri-capsular Nerve Group Block for Hip Fracture Analgesia

NCT ID: NCT05444803

Last Updated: 2023-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-06

Study Completion Date

2022-12-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to compare the analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spinal anesthesia is commonly used in patients undergoing hip fracture surgery. However the procedure of patient positioning to perform a spinal block is painful and may require the administration of IV analgesics or some regional anesthesia techniques such as femoral nerve block, fascia-iliaca compartment block, peri-capsular nerve group block. At the study, the investigators aimed to compare analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Anesthesia Analgesia Hip Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Femoral nerve block group

Thirty minutes before the placement of spinal block, patients will be receive a femoral nerve block with Bupivacaine.

Group Type OTHER

femoral nerve block

Intervention Type OTHER

Patients will be performed a femoral nerve block using bupivacaine thirty minutes before the performing of spinal block.

Peri-capsular nerve group block group

Thirty minutes before the placement of spinal block, patients will be receive a peri-capsular nerve group block with Bupivacaine.

Group Type OTHER

peri-capsular nerve group block

Intervention Type OTHER

Patients will be performed a peri-capsular nerve group block using bupivacaine thirty minutes before the performing of spinal block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

femoral nerve block

Patients will be performed a femoral nerve block using bupivacaine thirty minutes before the performing of spinal block.

Intervention Type OTHER

peri-capsular nerve group block

Patients will be performed a peri-capsular nerve group block using bupivacaine thirty minutes before the performing of spinal block.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with hip fracture scheduled for surgery under spinal anesthesia.

Exclusion Criteria

* hemorrhagic diathesis,
* peripheral neuropathy,
* allergy to local anesthetics,
* mental disorders,
* use of analgesics for 8 h before the performance of spinal block
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Antalya Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Safa Eroglu, M.D.

Role: PRINCIPAL_INVESTIGATOR

Antalya Traning and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Antalya Training and Research Hospital

Antalya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

safa1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.